Literature DB >> 19135613

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

Timothy Watson1, Eduard Shantsila, Gregory Y H Lip.   

Abstract

Atrial fibrillation is the most common sustained cardiac arrhythmia, which is associated with a high risk of stroke and thromboembolism. Increasing evidence suggests that the thrombogenic tendency in atrial fibrillation is related to several underlying pathophysiological mechanisms. Abnormal changes in flow are evident by stasis in the left atrium, and seen as spontaneous echocontrast. Abnormal changes in vessel walls-essentially, anatomical and structural defects-include progressive atrial dilatation, endocardial denudation, and oedematous or fibroelastic infiltration of the extracellular matrix. Additionally, abnormal changes in blood constituents are well described, and include haemostatic and platelet activation, as well as inflammation and growth factor changes. These changes result in the fulfilment of Virchow's triad for thrombogenesis, and accord with a prothrombotic or hypercoagulable state in this arrhythmia. In this Review, we present an overview of the established and purported mechanisms for thrombogenesis in atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135613     DOI: 10.1016/S0140-6736(09)60040-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  222 in total

1.  [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

Authors:  B Leithäuser; F Kasch; T Broemel; J-W Park
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

2.  Excision or exclusion of left atrial appendage?

Authors:  Hans-Hinrich Sievers
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

3.  Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.

Authors:  David Conen; Jorge A Wong; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Julie E Buring; Christine M Albert
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

4.  Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins.

Authors:  A V Ivanova; S V Ivanov; M L Lerman
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  [New oral anticoagulants in atrial fibrillation].

Authors:  R Veltkamp; W Hacke
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 6.  A narrative review of red blood cell distribution width as a marker for pulmonary embolism.

Authors:  Lindsay Hammons; Jason Filopei; David Steiger; Eric Bondarsky
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

Review 7.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

8.  Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

Review 9.  Safety and efficacy of new anticoagulants in patients with heart failure.

Authors:  Ron Pisters; Gregory Y H Lip
Journal:  Curr Heart Fail Rep       Date:  2013-03

10.  Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation.

Authors:  Dmitry A Zateyshchikov; Alexey N Brovkin; Dimitry A Chistiakov; Valery V Nosikov
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.